What are the risks of investing in CSTL?
C
What are the risks of investing in CSTL?
🦉
Castle Biosciences, Inc. (CSTL)
Company Overview
Sector / IndustryHealthcare / Medical - Diagnostics & Research
CEODerek J. Maetzold
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed...
Key Executives
| Name | Title |
|---|---|
| Camilla Zuckero | Vice President of Investor Relations & Corporate Affairs |
| Derek J. Maetzold | Founder, Chief Executive Officer, President & Director |
| Frank Stokes | Chief Financial Officer & Treasurer |
| Hillary Caruso | Chief of Staff |
| Jay Braxton | Vice President of Marketing & Brand Manager of Uveal Melanoma (UM) |
| Keli Greenberg | Vice President of Human Resources |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A